Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Cybersecurity Again In Spotlight As Hackers Breach CBER’s Database

This article was originally published in The Gray Sheet

Executive Summary

A hacker gained access to information from about 14,000 users of the Center for Biologics Evaluation and Research’s submission systems during the government shutdown.

You may also be interested in...

OIG Report Highlights FDA Cybersecurity Problems, Recommends Fixes

The oversight agency identified several vulnerabilities on FDA’s web site and databases after a cybersecurity breach last year allowed hackers to access data on thousands of FDA clients and raised concern with congressional leaders. FDA says it has fixed the identified issues.

HHS, HITRUST Team Up For Simulated Cyberattacks On Health Industry

HHS and the information security firm have formed CyberRX, a program that will conduct simulated cyberattacks to test health care industry information systems and medical devices.

Regulatory Briefs: Congress Investigates FDA Cybersecurity Breach; First Device For Migraines

Congress investigates a cybersecurity breach at FDA. Agency approved the first device to relieve migraine headache pain. More regulatory news.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts